Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Glioblastoma 3 Esophageal Neoplasms 3 Recurrence 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Brain Neoplasms 2 Thyroid Neoplasms 1 Pathologic Complete Response 1 Oligodendroglioma 1 Lymphoma, Follicular 1 Lymphatic Metastasis 1 Li-Fraumeni Syndrome 1 Gliosarcoma 1 Glioma 1 Ependymoma 1 Disease 1 DWI-MRI 1 Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Astrocytoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Lomustine 7 Filgrastim 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Diffusion Magnetic Resonance Imaging × Clear all

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡